Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synthetic Cell-Based Immunotherapies for Neurologic Diseases.
von Baumgarten L, Stauss HJ, Lünemann JD. von Baumgarten L, et al. Among authors: lunemann jd. Neurol Neuroimmunol Neuroinflamm. 2023 Jun 29;10(5):e200139. doi: 10.1212/NXI.0000000000200139. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37385738 Free PMC article. Review.
Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis.
Lünemann A, Tackenberg B, DeAngelis T, da Silva RB, Messmer B, Vanoaica LD, Miller A, Apatoff B, Lublin FD, Lünemann JD, Münz C. Lünemann A, et al. Among authors: lunemann jd. Int Immunol. 2011 Feb;23(2):139-48. doi: 10.1093/intimm/dxq463. Epub 2011 Jan 6. Int Immunol. 2011. PMID: 21212154 Free PMC article.
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD. Keller CW, et al. Among authors: lunemann jd. Ann Clin Transl Neurol. 2019 Dec;6(12):2586-2594. doi: 10.1002/acn3.50935. Epub 2019 Nov 4. Ann Clin Transl Neurol. 2019. PMID: 31682087 Free PMC article.
Impact of complement activation on clinical outcomes in multiple sclerosis.
Keller CW, Oechtering J, Wiendl H, Kappos L, Kuhle J, Lünemann JD. Keller CW, et al. Among authors: lunemann jd. Ann Clin Transl Neurol. 2021 Apr;8(4):944-950. doi: 10.1002/acn3.51334. Epub 2021 Mar 1. Ann Clin Transl Neurol. 2021. PMID: 33646629 Free PMC article.
Profiling Complement System Components in Primary CNS Vasculitis.
Deb-Chatterji M, Keller CW, Koch S, Wiendl H, Gerloff C, Magnus T, Lünemann JD. Deb-Chatterji M, et al. Among authors: lunemann jd. Cells. 2021 May 8;10(5):1139. doi: 10.3390/cells10051139. Cells. 2021. PMID: 34066885 Free PMC article.
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Hunter ZR, Kallmann B, Kleinschnitz C, Klotz L, Leussink V, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber MS, Weber F, Zettl UK, Ziemssen T, Zipp F; die Multiple Sklerose Therapie Konsensus Gruppe (MSTKG). Wiendl H, et al. Among authors: lunemann jd. Nervenarzt. 2021 Aug;92(8):773-801. doi: 10.1007/s00115-021-01157-2. Epub 2021 Jul 23. Nervenarzt. 2021. PMID: 34297142 Free PMC article. Review. German.
172 results